Wen Li,Xianming Wang,Wenxia Fan,Ping Zhao,Yau-Chi Chan,Shen Chen,Shiqiang Zhang,Xiangpeng Guo,Ya Zhang,Yanhua Li,Jinglei Cai,Dajiang Qin,Xingyan Li,Jiayin Yang,Tianran Peng,Daniela Zychlinski,Dirk Hoffmann,Ruosi Zhang,Kang Deng,Kwong-Man Ng,Bjorn Menten,Mei Zhong,Jiayan Wu,Zhiyuan Li,Yonglong Chen,Axel Schambach,Hung-Fat Tse,Duanqing Pei,Miguel A. Esteban

Abstract:Many human diseases share a developmental origin that manifests during childhood or maturity. Aneuploid syndromes are caused by supernumerary or reduced number of chromosomes and represent an extreme example of developmental disease, as they have devastating consequences before and after birth. Investigating how alterations in gene dosage drive these conditions is relevant because it might help treat some clinical aspects. It may also provide explanations as to how quantitative differences in gene expression determine phenotypic diversity and disease susceptibility among natural populations. Here, we aimed to produce induced pluripotent stem cell (iPSC) lines that can be used to improve our understanding of aneuploid syndromes. We have generated iPSCs from monosomy X [Turner syndrome (TS)], trisomy 8 (Warkany syndrome 2), trisomy 13 (Patau syndrome) and partial trisomy 11;22 (Emanuel syndrome), using either skin fibroblasts from affected individuals or amniocytes from antenatal diagnostic tests. These cell lines stably maintain the karyotype of the donors and behave like embryonic stem cells in all tested assays. TS iPSCs were used for further studies including global gene expression analysis and tissue-specific directed differentiation. Multiple clones displayed lower levels of the pseudoautosomal genes ASMTL and PPP2R3B than the controls. Moreover, they could be transformed into neural-like, hepatocyte-like and heart-like cells, but displayed insufficient up-regulation of the pseudoautosomal placental gene CSF2RA during embryoid body formation. These data support that abnormal organogenesis and early lethality in TS are not caused by a tissue-specific differentiation blockade, but rather involves other abnormalities including impaired placentation.

Generation of Induced Pluripotent Stem Cell Line iTAF15Xsk4 from Fibroblasts of a Patient with Microdeletion at Xq24

Generation of induced Pluripotent Stem Cells (UNIBSi008-A, UNIBSi008-B, UNIBSi008-C) from an Ataxia-Telangiectasia (AT) patient carrying a novel homozygous deletion in ATM gene

Derivation of Induced Pluripotent Stem Cells Line (RCPCMi009-A-1) with Knockout of the UBE2A Gene by CRISPR/Cas9 Genome Editing

Generation of an Induced Pluripotent Stem Cell Line from a Long QT Syndrome Patient Carrying KCNH2/1956C > A Mutation.

Modeling Abnormal Early Development with Induced Pluripotent Stem Cells from Aneuploid Syndromes

Derivation of Induced Pluripotent Stem Cells Line (RCPCMi009-A-1) with Knockout of the UBE2A Gene Using CRISPR/Cas9 Genome Editing

Generation of human induced pluripotent stem cell lines from a subject with UBAP1L-associated retinal dystrophy and CRISPR/cas9-corrected isogenic iPSC lines

Establishment of a transgene-free iPS cell line (SDQLCHi046-A) from a young patient bearing a HDAC8 mutation and suffering from Cornelia de Lange Syndrome

Generation of an Induced Pluripotent Stem Cell Line from an Individual with a Heterozygous RECQL4 Mutation.

Derivation of Four Ipsc Lines from a Male ASD Patient Carrying a Deletion in the Middle Coding Region of NRXN1α Gene (Nuigi039-a and NUIGi039-B) and a Male Sibling Control (Nuigi040-a and NUIGi040-B)

Generation of an Induced Pluripotent Stem Cell Line from an Ohtahara Syndrome Patient with the Hemizygous Mutation P.q503afs*28 (c.1507_1508del) in the ARX Gene.

Generation of Induced Pluripotent Stem Cells (ipscs) from a Retinoblastoma Patient Carrying a C.2663g>a Mutation in RB1 Gene.

Establishment of Ipsc Line from a Chinese Infant (Xachi012-A) with Jervell and Lange-Nielsen Syndrome Carrying Combined KCNQ1 Frameshift C.431delc(p.i145sfs*92) and Nonsense C.1175g > A (p.w392x) Variants and Two Ipsc Lines from the Parents (Xachi013-A, XACHi014-A).

Generation of an Induced Pluripotent Stem Cell Line SJTUXHi001-A from an Autism Spectrum Disorder Patient Carrying a Heterozygous Mutation in HDAC8 (P.p359s)

Generation of Human Ipscs from an Essential Thrombocythemia Patient Carrying a V501L Mutation in the MPL Gene.

Generation of Two Induced Pluripotent Stem Cell Lines from Patients with Unbalanced Translocation (3;22).

An integration-free iPSC line SDQLCHi065-A from a patient with down syndrome, possessing a 47, XY,+21, inv(9)(p12q21),16qh + karyotype

Induced pluripotent stem cell (iPSC) lines from two individuals carrying a homozygous (BGUi007-A) and a heterozygous (BGUi006-A) mutation in ELP1 for in vitro modeling of familial dysautonomia

Generation of a human induced pluripotent stem cell (iPSC) line from a patient with a CDKL5 gene mutation

Generation and genetic repair of two human induced pluripotent stem cell lines from patients with Epidermolysis Bullosa simplex associated with a heterozygous mutation in the translation initiation codon of KLHL24

Generation of an induced pluripotent stem cell line (SJTUGHi003-A) from a patient with Sorsby fundus dystrophy carrying c.484G>A mutation in TIMP3 gene